Dose Range Finding Study of MK-0941 in Patients With Type 2 Diabetes Mellitus on Insulin (MK-0941-007 AM3 EXT1 AM1)(TERMINATED)

NCT00767000 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

813

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: MK-0941
DRUG: Comparator: Placebo
BIOLOGICAL: Lantus
DRUG: Metformin

Sponsor

Merck Sharp & Dohme LLC